Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice

Diabetic cardiomyopathy (DCM) is an important cause of heart failure in diabetic patients. The present study sought to explore the potential effects of dihydromyricetin (DHM) on DCM and its possible mechanism. A diabetic model was induced by intraperitoneal injection of streptozotocin (STZ) in C57BL...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Lin, Jie, Luo, Jian, Han, Dong, Fan, Miaomiao, Guo, Tao, Tao, Ling, Yuan, Ming, Yi, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379084/
https://www.ncbi.nlm.nih.gov/pubmed/28421194
http://dx.doi.org/10.1155/2017/3764370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379084/
https://www.ncbi.nlm.nih.gov/pubmed/28421194
http://dx.doi.org/10.1155/2017/3764370

Ejemplares similares